Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group

Impact of a pharmacist-directed intervention in postmenopausal women after fracture

(2012) R. M. F. Heilmann et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Osteoporosis Telephonic Intervention to Improve Medication Regimen Adherence

(2012) Daniel H. Solomon   ARCHIVES OF INTERNAL MEDICINE

A new taxonomy for describing and defining adherence to medications

(2012) Bernard Vrijens et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

(2012) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Use of a Decision Aid to Improve Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial

(2011) Victor M. Montori et al.   AMERICAN JOURNAL OF MEDICINE

Monitoring of bone turnover markers does not improve persistence with ibandronate treatment

(2011) Christian Roux et al.   JOINT BONE SPINE

Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial

(2011) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

(2011) N. Freemantle et al.   OSTEOPOROSIS INTERNATIONAL

The societal burden of poor persistence to treatment of osteoporosis in Sweden

(2010) Erik Landfeldt et al.   BONE

Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications

(2010) Mickaël Hiligsmann et al.   CALCIFIED TISSUE INTERNATIONAL

The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients

(2010) Mickaël Hiligsmann et al.   HEALTH POLICY

Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women

(2010) P. S. M. Lai et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates

(2010) S. Ojeda-Bruno et al.   OSTEOPOROSIS INTERNATIONAL

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

(2010) D. L. Kendler et al.   OSTEOPOROSIS INTERNATIONAL

Patient education in groups increases knowledge of osteoporosis and adherence to treatment: A two-year randomized controlled trial

(2010) Dorthe Nielsen et al.   PATIENT EDUCATION AND COUNSELING

Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence

(2010) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

(2009) Ethel S. Siris et al.   AMERICAN JOURNAL OF MEDICINE

A framework for planning and critiquing medication compliance and persistence research using prospective study designs

(2009) Femida H. Gwadry-Sridhar et al.   CLINICAL THERAPEUTICS

Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence

(2009) Véronique Rabenda et al.   EXPERT OPINION ON PHARMACOTHERAPY

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

(2009) T. Gleeson et al.   OSTEOPOROSIS INTERNATIONAL

Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial

(2009) N. Yuksel et al.   OSTEOPOROSIS INTERNATIONAL

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

(2009) I. Imaz et al.   OSTEOPOROSIS INTERNATIONAL